Delivery Order #SPE2DR26FK4NN

Delivery Order for ROTATEQ Vaccine by AmerisourceBergen

This award represents a delivery order contract issued to AmerisourceBergen Drug Corp, a prominent pharmaceutical distribution company. The contract involves the procurement of the ROTATEQ vaccine, supplied in 2ml doses, highlighting a crucial public health service focused on immunization. The contract is a part of a broader indefinite delivery vehicle (IDV) agreement aimed at pharmaceutical distribution, underscoring its vital role in ensuring timely and reliable access to essential vaccines. The scope involves prompt delivery of the specified vaccine to a designated location in Conshohocken, Pennsylvania, within a short timeframe, demonstrating responsiveness in pharmaceutical supply chains. This award was made under a subsidiary delivery order linked to a previously established IDV contract for pharmaceutical products, reflecting continued collaboration and procurement efficiency. The contract was presumably awarded through an established procurement process under the IDV framework, emphasizing known reliability rather than open competitive bidding for this specific delivery. The timeline is concise, with performance scheduled over a two-day period in early March 2026, marking a swift fulfillment requirement. Overall, this award underlines the government’s commitment to maintaining uninterrupted supply of critical vaccines through trusted partners in pharmaceutical distribution.

Description

4571027956!ROTATEQ VACCINE 2ML

View original record